9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025

被引:107
作者
American Diabetes AssociationProfessional Practice Committee, Nuha A.
Elsayed, Nuha A.
Mccoy, Rozalina G.
Aleppo, Grazia
Bajaj, Mandeep
Balapattabi, Kirthikaa
Beverly, Elizabeth A.
Briggs Early, Kathaleen
Bruemmer, Dennis
Echouffo-Tcheugui, Justin B.
Ekhlaspour, Laya
Gaglia, Jason L.
Garg, Rajesh
Girotra, Monica
Khunti, Kamlesh
Lal, Rayhan
Lingvay, Ildiko
Matfin, Glenn
Neumiller, Joshua J.
Pandya, Naushira
Pekas, Elizabeth J.
Pilla, Scott J.
Polsky, Sarit
Segal, Alissa R.
Seley, Jane Jeffrie
Stanton, Robert C.
Bannuru, Raveendhara R.
机构
关键词
CONSENSUS GUIDELINES 2022; INITIAL COMBINATION THERAPY; ALPELISIB PLUS FULVESTRANT; MULTIPLE DAILY INJECTIONS; ONCE-WEEKLY SEMAGLUTIDE; REGULAR U-500 INSULIN; BASAL-BOLUS REGIMEN; HYBRID CLOSED-LOOP; SEVERE HYPOGLYCEMIA; OPEN-LABEL;
D O I
10.2337/dc25-S009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
引用
收藏
页码:S181 / S206
页数:26
相关论文
共 242 条
[1]   A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients [J].
Abd El Aziz, Mirna S. ;
Kahle, Melanie ;
Meier, Juris J. ;
Nauck, Michael A. .
DIABETES OBESITY & METABOLISM, 2017, 19 (02) :216-227
[2]   Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial [J].
Abdul-Ghani, M. A. ;
Puckett, C. ;
Triplitt, C. ;
Maggs, D. ;
Adams, J. ;
Cersosimo, E. ;
DeFronzo, R. A. .
DIABETES OBESITY & METABOLISM, 2015, 17 (03) :268-275
[3]   Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A3-year follow-up of the Qatar study [J].
Abdul-Ghani, Muhammad ;
Migahid, Osama ;
Megahed, Ayman ;
DeFronzo, Ralph A. ;
Al-Ozairi, Ebaa ;
Jayyousiv, Amin .
DIABETES OBESITY & METABOLISM, 2020, 22 (12) :2287-2294
[4]   Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91) [J].
Adler, Amanda, I ;
Coleman, Ruth L. ;
Leal, Jose ;
Whiteley, William N. ;
Clarke, Philip ;
Holman, Rury R. .
LANCET, 2024, 404 (10448) :145-155
[5]   Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial [J].
Ahmann, Andrew J. ;
Capehorn, Matthew ;
Charpentier, Guillaume ;
Dotta, Francesco ;
Henkel, Elena ;
Lingvay, Ildiko ;
Holst, Anders G. ;
Annett, Miriam P. ;
Aroda, Vanita R. .
DIABETES CARE, 2018, 41 (02) :258-266
[6]   Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial [J].
Ahren, Bo ;
Hirsch, Irl B. ;
Pieber, Thomas R. ;
Mathieu, Chantal ;
Gomez-Peralta, Fernando ;
Hansen, Troels Krarup ;
Philotheou, Areti ;
Birch, Sune ;
Christiansen, Erik ;
Jensen, Thomas Jon ;
Buse, John B. .
DIABETES CARE, 2016, 39 (10) :1693-1701
[7]   Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study [J].
Akturk, Halis Kaan ;
Snell-Bergeon, Janet K. ;
Rewers, Amanda ;
Klaff, Leslie J. ;
Bode, Bruce W. ;
Peters, Anne L. ;
Bailey, Timothy S. ;
Garg, Satish K. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (10) :639-647
[8]   Efficacy of insulin dosing algorithms for high-fat high-protein mixed meals to control postprandial glycemic excursions in people living with type 1 diabetes: A systematic review and meta-analysis [J].
Al Balwi, Rana ;
Al Madani, Wedad ;
Al Ghamdi, Amal .
PEDIATRIC DIABETES, 2022, 23 (08) :1635-1646
[9]  
Aleppo G, 2017, J ENDOCR SOC, V1, P1445, DOI 10.1210/js.2017-00388
[10]  
American Diabetes Association, State Insulin Copay Caps